Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Lipsky

Showing results (11-20 of 427) with videos related to

Pageof 43
Sort By:
The Journal of Rheumatology. Supplement|October 14, 2000
Defining COX-2 inhibitorsP E Lipsky
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 24, 2001
[COX-2--what are the clinical implications?]P E Lipsky
The American Journal of Medicine|February 15, 2001
Introduction. The role of COX-2-specific inhibitors in clinical practiceP E Lipsky
Nature Immunology|August 30, 2001
Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivityP E Lipsky
Agents and Actions. Supplements|January 1, 1984
Remittive therapy in rheumatoid arthritis: clinical uses and mechanisms of actionP E Lipsky
The American Journal of Medicine|October 31, 1983
Remission-inducing therapy in rheumatoid arthritisP E Lipsky
Contemporary Topics in Molecular Immunology|January 1, 1985
Role of interleukin-1 in human B-cell activationP E Lipsky
The American Journal of Medicine|July 2, 1999
The clinical potential of cyclooxygenase-2-specific inhibitorsP E Lipsky
The American Journal of Medicine|February 15, 2001
Recommendations for the clinical use of cyclooxygenase-2-specific inhibitorsP E Lipsky
The American Journal of Medicine|February 10, 1998
Algorithms for the diagnosis and management of musculoskeletal complaints. IntroductionP E Lipsky
Pageof 43

Showing results (11-20 of 427) with videos related to

Sort By:
Pageof 43
The Journal of Rheumatology. Supplement|October 14, 2000
Defining COX-2 inhibitorsP E Lipsky
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|February 24, 2001
[COX-2--what are the clinical implications?]P E Lipsky
The American Journal of Medicine|February 15, 2001
Introduction. The role of COX-2-specific inhibitors in clinical practiceP E Lipsky
Nature Immunology|August 30, 2001
Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivityP E Lipsky
Agents and Actions. Supplements|January 1, 1984
Remittive therapy in rheumatoid arthritis: clinical uses and mechanisms of actionP E Lipsky
The American Journal of Medicine|October 31, 1983
Remission-inducing therapy in rheumatoid arthritisP E Lipsky
Contemporary Topics in Molecular Immunology|January 1, 1985
Role of interleukin-1 in human B-cell activationP E Lipsky
The American Journal of Medicine|July 2, 1999
The clinical potential of cyclooxygenase-2-specific inhibitorsP E Lipsky
The American Journal of Medicine|February 15, 2001
Recommendations for the clinical use of cyclooxygenase-2-specific inhibitorsP E Lipsky
The American Journal of Medicine|February 10, 1998
Algorithms for the diagnosis and management of musculoskeletal complaints. IntroductionP E Lipsky
Pageof 43